ADMA — ADMA BIOLOGICS INC

Ownership history in Perpetual Ltd  ·  4 quarters on record

This page tracks every 13F SEC filing in which Perpetual Ltd reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.85% (2025 Q1)
Avg. % of fund
0.65%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 2,119,291 -774,995 -26.8% 0.39% $31.1M $14.66
2025 Q2 REDUCED 2,894,286 -657,527 -18.5% 0.62% $52.7M $18.21
2025 Q1 REDUCED 3,551,813 -80,864 -2.2% 0.85% $70.5M $19.84
2024 Q4 INITIATED 3,632,677 — — 0.73% $62.3M $17.15
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Perpetual Ltd Holdings